Qyuns Therapeutics Co., Ltd. Class H (HK:2509)

:2509

2509

Qyuns Therapeutics Co., Ltd. Class H

RESEARCH TOOLSreports

Compare Qyuns Therapeutics Co., Ltd. Class H (2509) vs. Competitors

1 Followers

Comparison Results

2509

Qyuns Therapeutics Co., Ltd. Class H

HK$28.58

HK$4.66B

12.32

157.79%

3 Buy

0 Hold

0 Sell

Strong Buy

TOT BIOPHARM International Co. Ltd.

HK$2.50

HK$3.76B

-16.66

185.88%

―

JW (Cayman) Therapeutics Co. Ltd.

HK$2.50

HK$949.56M

-1.73

58.33%

―

Clover Biopharmaceuticals Ltd.

HK$2.37

HK$4.00B

-13.26

1373.68%

―

Sirnaomics Ltd.

HK$8.00

HK$806.45M

-6.45

137.10%

―

Transcenta Holding Limited

HK$2.25

HK$1.24B

-3.97

152.25%

―

xxxxxxxxxxxxx

2509 vs 6628

xxxxxxxxxxxxx

Performance Comparison

HK:2509

Qyuns Therapeutics Co., Ltd. Class H

20.52

12.22

147.23%

HK:1875

TOT BIOPHARM International Co. Ltd.

4.86

3.23

198.16%

HK:2126

JW (Cayman) Therapeutics Co. Ltd.

2.28

0.76

50.00%

HK:2197

Clover Biopharmaceuticals Ltd.

3.08

2.88

1440.00%

HK:2257

Sirnaomics Ltd.

7.35

4.21

134.08%

HK:6628

Transcenta Holding Limited

2.80

1.57

127.64%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >